Geely (175 HK) Undergoing the period of transformation

28 Apr 2023

Company Profile
Geely is one of the leading enterprises in China’s self-brand passenger vehicles
manufacturers. The Company’s products include six major brands: Geely, Geometry, Lynk,
Zeekr, Livan, and Galaxy, covering the A0 to B-class passenger vehicles market.
Investment Summary
The High Revenue Growth Is Attributed to the Rise in Single Vehicle Prices of Zeekr
According to the recently released FR2022 result, Geely reported a gross revenue of
RMB148 billion, up 45.6% yoy, exceeding market expectation of RMB132.4 billion
(Bloomberg consensus). It recorded a net profit attributable to shareholders of RMB5.26
billion, up 8.5% yoy, higher than market expectation of RMB4.82 billion. The EPS was
RMB0.505, slightly lower than our previous estimate of RMB0.53. The dividend per share
was HK$0.21, unchanged from the previous year.
In 2022, Geely’s sales volume totalled 1,430 thousand units, up 8% yoy. Specifically, the
sales volume in the domestic market increased 2% to 1,230 thousand units, while the export
sales volume surged 72% to 198 thousand units. Benefiting from the average sales price of
Zeekr exceeding RMB336 thousand, the average sales revenue from single vehicles grew by
30% year-on-year, reaching RMB103 thousand (excluding Ruilan Auto and Lynk & Co),
driving the Company’s overall revenue growth to be much higher than the sales volume
growth.
The Profitability Is Largely Affected by Only the New Energy Transformation Cost
Total gross margin decreased by 3 ppts to 14.1%, mainly due to rising raw material costs and
higher new energy transformation cost in the initial stage. The Company’s NEV sales volume
increased by 300% year-on-year to 329 thousand units, and the proportion climbed by 16.7
ppts to 22.9% from 6.2% in the same period last year. The low gross profit of new energy
vehicles in the initial transformation affected the overall gross margin. In 2022, Zeekr
contributed to revenue of approximately RMB31.8 billion and a consolidated loss of
RMB1.38 billion.
In terms of expenses, the administrative expense ratio and sales expense ratio decreased by
0.8 ppts and 0.6 ppts, respectively. Due to the increased R&D investment in
intelligentisation and electrification, the R&D expenses increased by 22.6% to RMB6.77
billion, of which RMB1.97 billion or 29% was expensed. Capital expenses in 2022 were
RMB10.3 billion (RMB6.1 billion in 2021), exceeding the RMB9.2 billion budgeted at the
beginning of the year, mainly due to higher R&D investment to accelerate the
transformation to new energy and intelligentisation. The Company’s capital expense budget
for 2023 is RMB14 billion. With the Company’s comprehensive transformation to new
energy, R&D investment will continue to increase. Amid the new energy and
intelligentisation, the competition in the industry will continue to intensify. It is expected
that the Company’s R&D expenses will continue to grow rapidly in the next few years.

About the author

Zhang Jing

Phillip Securities (HK)

Bachelor Degree in Tongji University of Engineering; Master Degree in East China Normal University of finance. Currently covering the automobile and air sectors. She has years of experience in investment research and is good at combining analysis for the companies with industry prospects.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com